Low-dose interleukin-2 selectively corrects regulatory T cell defects in patients with systemic lupus erythematosus

Caroline von Spee-Mayer, Elise Siegert, Dimas Abdirama, Angelika Rose, Anika Klaus, Tobias Alexander, Philipp Enghard, Birgit Sawitzki, Falk Hiepe, Andreas Radbruch, Gerd-RĂ¼diger Burmester, Gabriela Riemekasten, Jens Y Humrich

Fingerprint

Dive into the research topics of 'Low-dose interleukin-2 selectively corrects regulatory T cell defects in patients with systemic lupus erythematosus'. Together they form a unique fingerprint.

Immunology and Microbiology